Wolfson Lara J, Gasse François, Lee-Martin Shook-Pui, Lydon Patrick, Magan Ahmed, Tibouti Abdelmajid, Johns Benjamin, Hutubessy Raymond, Salama Peter, Okwo-Bele Jean-Marie
World Health Organization, Geneva, Switzerland.
Bull World Health Organ. 2008 Jan;86(1):27-39. doi: 10.2471/blt.07.045096.
To estimate the cost of scaling up childhood immunization services required to reach the WHO-UNICEF Global Immunization Vision and Strategy (GIVS) goal of reducing mortality due to vaccine-preventable diseases by two-thirds by 2015.
A model was developed to estimate the total cost of reaching GIVS goals by 2015 in 117 low- and lower-middle- income countries. Current spending was estimated by analysing data from country planning documents, and scale-up costs were estimated using a bottom-up, ingredients-based approach. Financial costs were estimated by country and year for reaching 90% coverage with all existing vaccines; introducing a discrete set of new vaccines (rotavirus, conjugate pneumococcal, conjugate meningococcal A and Japanese encephalitis); and conducting immunization campaigns to protect at-risk populations against polio, tetanus, measles, yellow fever and meningococcal meningitis.
The 72 poorest countries of the world spent US$ 2.5 (range: US$ 1.8-4.2) billion on immunization in 2005, an increase from US$ 1.1 (range: US$ 0.9-1.6) billion in 2000. By 2015 annual immunization costs will on average increase to about US$ 4.0 (range US$ 2.9-6.7) billion. Total immunization costs for 2006-2015 are estimated at US$ 35 (range US$ 13-40) billion; of this, US$ 16.2 billion are incremental costs, comprised of US$ 5.6 billion for system scale-up and US$ 8.7 billion for vaccines; US$ 19.3 billion is required to maintain immunization programmes at 2005 levels. In all 117 low- and lower-middle-income countries, total costs for 2006-2015 are estimated at US$ 76 (range: US$ 23-110) billion, with US$ 49 billion for maintaining current systems and $27 billion for scaling-up.
In the 72 poorest countries, US$ 11-15 billion (30%-40%) of the overall resource needs are unmet if the GIVS goals are to be reached. The methods developed in this paper are approximate estimates with limitations, but provide a roadmap of financing gaps that need to be filled to scale up immunization by 2015.
评估扩大儿童免疫服务规模所需的成本,以实现世界卫生组织-联合国儿童基金会全球免疫远景与战略(GIVS)提出的到2015年将疫苗可预防疾病导致的死亡率降低三分之二的目标。
建立一个模型来估算117个低收入和中低收入国家到2015年实现GIVS目标的总成本。通过分析各国规划文件中的数据估算当前支出,并采用自下而上的基于构成要素的方法估算扩大规模的成本。按国家和年份估算实现所有现有疫苗90%覆盖率、引入一组特定新疫苗(轮状病毒、结合型肺炎球菌、结合型A群脑膜炎球菌和日本脑炎疫苗)以及开展免疫运动以保护高危人群免受脊髓灰质炎、破伤风、麻疹、黄热病和脑膜炎球菌性脑膜炎侵害的财务成本。
2005年世界上72个最贫穷国家的免疫支出为25亿美元(范围:18亿-42亿美元),高于2000年的11亿美元(范围:9亿-16亿美元)。到2015年,年度免疫成本平均将增至约40亿美元(范围:29亿-67亿美元)。2006 - 2015年的免疫总成本估计为350亿美元(范围:130亿-至400亿美元);其中,162亿美元为增量成本,包括56亿美元用于系统扩大规模和87亿美元用于疫苗;需要193亿美元将免疫计划维持在2005年的水平。在所有117个低收入和中低收入国家,2006 - 2015年的总成本估计为760亿美元(范围:230亿-1100亿美元),其中490亿美元用于维持现有系统,270亿美元用于扩大规模。
在72个最贫穷国家,如果要实现GIVS目标,总体资源需求中有110亿-150亿美元(30%-40%)未得到满足。本文所采用的方法是有局限性的近似估算,但提供了到2015年扩大免疫规模所需填补的资金缺口路线图。